We are live on ! Find out more
QNCX icon

Quince Therapeutics
QNCX

62 hedge funds and large institutions have $67.5M invested in Quince Therapeutics in 2025 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 20 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

525% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 4

400% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 4

251% more capital invested

Capital invested by funds: $19.2M → $67.5M (+$48.3M)

51% more funds holding

Funds holding: 41 → 62 (+21)

47% more call options, than puts

Call options by funds: $396K | Put options by funds: $270K

0.07% more ownership

Funds ownership: 0.11% → 0.18% (+0.07%)

Holders
62
Holders Change
+21
Holders Change %
+51.22%
% of All Funds
0.75%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
20
Reduced
4
Closed
4
Calls
$396K
Puts
$270K
Net Calls
+$126K
Net Calls Change
+$61K

Top Buyers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$5.66M
2
WP
Woodline Partners
California
+$4.88M
3
SCM
Superstring Capital Management
New York
+$2.16M
4
SC
Stempoint Capital
New York
+$1.86M
5
Jane Street
Jane Street
New York
+$1.22M

Top Sellers

Rank Fund Capital Flow
1
ACM
ADAR1 Capital Management
Texas
-$1.84M
2
NCM
Nantahala Capital Management
Connecticut
-$1.01M
3
Millennium Management
Millennium Management
New York
-$494K
4
SC
Shay Capital
New York
-$223K
5
Mariner
Mariner
Kansas
-$200K
Name Holding Trade Value Shares
Change 		Change in
Stake
EGM
51
Engineers Gate Manager
New York
$40.8K +$30.7K +61 New
NPT
52
Nixon Peabody Trust
Massachusetts
$37.3K – – –
Morgan Stanley
53
Morgan Stanley
New York
$35.6K +$17.6K +35 +194%
Wells Fargo
54
Wells Fargo
California
$23.4K – – –
Citigroup
55
Citigroup
New York
$21.7K +$16.1K +32 New
AF
56
Allworth Financial
California
$5.03K +$4.03K +8 New
Osaic Holdings
57
Osaic Holdings
Arizona
$2.77K – – –
JP Morgan Chase
58
JP Morgan Chase
New York
$1.57K – – –
JFG
59
JDM Financial Group
Texas
$1.14K – – –
PA
60
Parallel Advisors
California
$988 – – –
Jones Financial Companies
61
Jones Financial Companies
Missouri
$446 +$503 +1 New
HC
62
Hurley Capital
New York
$405 – – –
SS
63
SBI Securities
Japan
$261 – – –
WIM
64
Westside Investment Management
California
$251 – – –
Fidelity Investments
65
Fidelity Investments
Massachusetts
$235 – – –
BNP Paribas Financial Markets
66
BNP Paribas Financial Markets
France
$27 – – –
Barclays
67
Barclays
United Kingdom
$13 – – –
SC
68
Shay Capital
New York
– -$223K -685 Closed
Mariner
69
Mariner
Kansas
– -$200K -612 Closed
ASN
70
Advisory Services Network
Georgia
– -$8.96K -28 Closed
HI
71
Harbour Investments
Wisconsin
– -$163 -1 Closed
1 2
3

QNCX Hedge Fund Activity: Q4 2025 in Review

62 of the 8,228 institutional investors tracked by Wall St. Rank reported a position in Quince Therapeutics (QNCX) for Q4 2025, worth a combined $67.5M — up 251% from $19.2M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new QNCX positions and 4 closed out — a net gain of 21 holders — while 20 added to existing stakes and 4 trimmed.

The largest buyer was Adage Capital Partners, opening a new position worth an estimated $5.66M. The largest seller was ADAR1 Capital Management, cutting an estimated $1.84M.

  • 62 institutional investors held Quince Therapeutics (QNCX) as of Q4 2025, up from 41 in Q3 2025.
  • Funds reported $67.5M of Quince Therapeutics stock for Q4 2025, up 251% quarter-over-quarter.
  • 25 funds opened new Quince Therapeutics positions in Q4 2025 and 4 closed out, a net change of +21 holders.
  • The largest Quince Therapeutics buyer in Q4 2025 was Adage Capital Partners, an estimated $5.66M added.
  • The largest Quince Therapeutics seller in Q4 2025 was ADAR1 Capital Management, an estimated $1.84M sold.

Based on aggregated 13F filings for Q4 2025.